Fungal central nervous system infections: prevalence and diagnosis

References

• Scully EP, Baden LR, Katz JT. Fungal brain infections. Curr Opin Neurol 2008;21(3):347-52
   PubMed Web of Science ®Google Scholar
• Raparia K, Powell Z, Cernoch P, Takei H. Cerebral mycosis: 7-year retrospective series in a tertiary center. Neuropathology 2010;30(3):218-23
   PubMedGoogle Scholar
• Desalermos A, Kourkoumpetis TK, Mylonakis E. Update on the epidemiology and management of cryptococcal meningitis. Expert Opin Pharmacother 2012;13(6):1-7
   PubMedGoogle Scholar
• Pukkila-Worley R, Mylonakis E. Epidemiology and management of cryptococcal meningitis: developments and challenges. Expert Opin Pharmacother 2008;9(4):551-60
   PubMed Web of Science ®Google Scholar
• Conen A, Weisser M, Hohler D, et al. Hormographiella aspergillata: an emerging mould in acute leukaemia patients? Clin Microbiol Infect 2011;17(2):273-7
   PubMedGoogle Scholar
• Park BJ, Pappas PG, Wannemuehler KA, et al. Invasive non-Aspergillus mold infections in transplant recipients. United States. 2001-2006. Emerg Infect Dis 2011;17(10):1855-64
   PubMedGoogle Scholar
• Casadevall A, Pirofski LA. Exserohilum rostratum fungal meningitis associated with methylprednisolone injections. Future Microbiol 2013;8(2):135-7
   PubMed Web of Science ®Google Scholar
• Tan IL, Smith BR, von Geldern G, et al. HIV-associated opportunistic infections of the CNS. Lancet Neurol 2012;11(7):605-17
   PubMed Web of Science ®Google Scholar
• Kourkoumpetis TK, Desalermos A, Muhammed M, Mylonakis E. Central nervous system aspergillosis. Series of 14 cases from a general hospital and review of 123 cases from the literature. Medicine (Baltimore) 2012;91(6):328-36
   PubMed Web of Science ®Google Scholar
• Anoop P, Stanford M, Saso R, Dearden CE. Ocular and cerebral aspergillosis in a non-neutropenic patient following alemtuzumab and methyl prednisolone treatment for chronic lymphocytic leukaemia. J Infect Chemother 2010;16(2):150-1
   PubMedGoogle Scholar
• Reisfled-Zadok S, Elis A, Szyper-Kravitz M, et al. Cryptococcal meningitis in chronic lymphocytic leukemia patients. Isr Med Assoc J 2009;11(7):437-9
   PubMedGoogle Scholar
• Schmidt-Hieber M, Zweigner J, et al. Central nervous system infections in immunocompromised patients: update on diagnostics and therapy. Leuk Lymphoma 2009;50(1):24-36
   PubMed Web of Science ®Google Scholar
• Kim HJ, Park YJ, Kim WU, et al. Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of catholic University of Korea. Lupus 2009;18(7):661-6
   PubMedGoogle Scholar
• Vinicki JP, Catalan Pellet S, Pappalardo C, et al. Invasive fungal infections in argentine patients with systemic lupus erythematosus. Lupus 2013;22(9):892-8
   PubMedGoogle Scholar
• Arce-Salinas CA, Perez-Silca E. Mucormycosis complications in systemic lupus erythematosus. Lupus 2010;19(8):985-8
   PubMed Web of Science ®Google Scholar
• Hage CA, Bowyer S, Tarvin SE, et al. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis 2010;50(1):85-92
   PubMed Web of Science ®Google Scholar
• Agarwal R, Kalita J, Marak RSK, Misra UK. Spectrum of fungal infection in a neurology tertiary care center in India. Neurol Sci 2012;33(6):1305-10
   PubMedGoogle Scholar
• Ranganath S, McGhie TA, LaRosaS et al. Clinical and laboratory diagnosis of central nervous system histoplasmosis. Am J Med 2012;125(10):e1-2
   PubMedGoogle Scholar
• Safdieh JE, Mead PA, Sepkowitz KA, et al. Bacterial and fungal meningitis in patients with cancer. Neurology 2008;70(12):943-7
   PubMedGoogle Scholar
• Zunt JR, Baldwin KJ. Chronic and subacute meningitis. Continuum (Minneap Minn) 2012;18(6):1290-318
   PubMedGoogle Scholar
• Mathur M, Johnson CE, Sze G. Fungal infections of the central nervous system. Neuroimaging Clin N Am 2012;22(4):609-32
   PubMedGoogle Scholar
• Gabelmann A, Klein S, Kern W, et al. Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients. Eur J Neurol 2007;14(5):548-55
   PubMedGoogle Scholar
• Gupta RK, Jobanputra KJ, Yadav A. MR spectroscopy in brain infections. Neuroimaging Clin N Am 2013;23(3):475-98
   PubMedGoogle Scholar
• Hauck EF, McGinnis M, Nauta HJ. Cerebral phaeohyphomycosis mimics high-grade astrocytoma. J Clin Neurosci 2008;15(9):1061-6
   PubMedGoogle Scholar
• Gemmel F, Dumarey N, Welling M. Future diagnostic agents. Semin Nucl Med 2009;39(1):11-26
   PubMed Web of Science ®Google Scholar
• Lupetti A, de Boer MG, Erba P, et al. Radiotracers for fungal infection imaging. Med Mycol 2011;49(Suppl 1):S62-9
   PubMedGoogle Scholar
• Hot A, Maunoury C, Poiree S, et al. Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect 2011;17(3):409-17
   PubMedGoogle Scholar
• Pruitt AA. CNS infections in patients with cancer. Continuum (Minneap Minn) 2012;18(2):384-405
   PubMedGoogle Scholar
• Jackson A, van der Horst C. New insights in the prevention, diagnosis and treatment of cryptococcal meningitis. Curr HIV/AIDS Rep 2012;9(3):267-77
   PubMed Web of Science ®Google Scholar
• Mikulska M, Furfaro E, Del Bono V, et al. 1-3)-β-D-Glucan cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. Clin Infect Dis 2013;56(10):1511-12
   PubMed Web of Science ®Google Scholar
• Hummel M, Spiess B, Kentouche K, et al. Detection of Aspergillus. DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay. J Clin Microbiol 2005;44(11):3989-93
   Google Scholar
• Binnicker MJ, Popa AS, Catania J, et al. Meningeal coccidioidomycosis diagnosed by real-time polymerase chain reaction analysis of cerebrospinal fluid. Mycopathologia 2011;171(4):285-9
   PubMed Web of Science ®Google Scholar
• Antinori S, Corbellino M, Meroni L, et al. Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect 2013;66(3):213-38
   Google Scholar
• Chignard M, Balloy V, Sallenave JM, Si-Tahar M. Role of toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromised hosts. Clin Immunol 2007;124(3):238-43
   PubMedGoogle Scholar
• Ferwenda B, Ferwenda G, Plantinga TS, et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009;361(18):1760-7
   PubMedGoogle Scholar
• Ramirez-Ortiz ZG, Means TK. The role of dendritic cells in the innate recognition of pathogenic fungi (A. fumigatus, C. neoformans and C. albicans). Virulence 2012;3(7):635-46
   PubMed Web of Science ®Google Scholar
• Klont RR, Mennink-Kersten M, Verweij PE. Utility of Aspergillus detection in specimens other than serum specimens. Clin Infect Dis 2004;39(10):1467-74
   PubMed Web of Science ®Google Scholar
• Skiada A, Vrana L, Polychronopoulou H, et al. Disseminated zygomycosis with involvement of the central nervous system. Clin Microbiol Infect 2009;15(Suppl 5):46-9
   PubMedGoogle Scholar
• Sasaki T, Mineta M, Kobayashi K, et al. Zygomycotic invasion of the central nervous system. Jpn J Radiol 2010;28(5):376-80
   PubMedGoogle Scholar
• De Yao JT, Al-Ameri A, Garcia-Manero G, Quintas-Cardama A. Infrequent presentations of mucormycosis in patients with myelodysplastic syndrome and acute leukemia: case series and review of the literature. Clin Lymphoma. Myeloma Leuk 2011;11(5):446-51
   PubMedGoogle Scholar
• Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008;21(1):157-97
   PubMed Web of Science ®Google Scholar
• Badali H, de Hoog GS, Curfs-Breuker I, et al. Use of amplified fragment length polymorphism to identify 4 Cladophialophora strains related to cerebral Phaeohyphomycosis with in vitro antifungal susceptibility. J Clin Microbiol 2010;48(7):2350-6
   PubMedGoogle Scholar
• Al-Tawfiq JA, Boukhamseen A. Cerebral phaeohyphomycosis due to Rhinocladiellamackenziei (formerly Ramichloridiummackenziei): case presentation and literature review. J Infect Public Health 2011;4(2):96-102
   PubMedGoogle Scholar
• Huang WM, Fan YM, Li W, Yang WW. Brain abscess caused by Cladophialophora bantiana in China. J Med Microbiol 2011;60(Pt 12):1872-4
   PubMedGoogle Scholar
• Verduyn Lunel FM, Voss A, Kuijper EJ, et al. Detection of the Candida antigen mannan in cerebrospinal fluid specimens from patients suspected in having Candida meningitis. J Clin Microbiol 2004;42(2):867-70
   PubMedGoogle Scholar
• El Khoury J. The blood-brain barrier and pathogens. Hadrian's wall or a Dardanian gate? Virulence 2012;3(2):157-8
   PubMed Web of Science ®Google Scholar
• Liu TB, Perlin DS, Xue C. Molecular mechanisms of cryptococcal meningitis. Virulence 2012;3(2):173-81
   PubMed Web of Science ®Google Scholar
• Garg M. Update on emerging infections: news from the Centers for Disease Control and Prevention. Cryptococcus gattii. Ann Emerg Med 2011;57(1):62-3
   PubMedGoogle Scholar
• Marr KA. Cryptococcus gattii as an important fungal pathogen of western North America. Expert Rev Anti Infect Ther 2012;10(6):637-43
   PubMed Web of Science ®Google Scholar
• Byrnes EJ III, Bartlett KH, Perfect JR, Heitman J. Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect 2011;13(11):895-907
   PubMedGoogle Scholar
• Galanis E, MacDougall L. Epidemiology of Cryptococcus gattii, British Columbia. Canada. 1999–2007. Emerg Infect Dis 2010;16(2):251-7
   PubMedGoogle Scholar
• Brizendine KD, Pappas PG. Cryptococcal meningitis: current approaches to management in patients with and without AIDS. Curr Infect Dis Rep 2010;12(4):299-305
   Google Scholar
• Marr KA, Datta K, Pirofski LA, Barnes R. Cryptococcus gattii infection in healthy hosts: a sentinel for subclinical immunodeficiency? Clin Infect Dis 2012;54:153
   PubMed Web of Science ®Google Scholar
• MacDougall L, Fyfe M, Romney M, et al. Risk factors for Cryptococcus gattii infection, British Columbia, Canada. Emerg Infect Dis 2011;17(2):193-9
   PubMedGoogle Scholar
• Haddow LJ, Colebunders R, Meinties G, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1 infected individuals: proposed clinical case definitions. Lancet Infect Dis 2010;10(11):791-802
   PubMed Web of Science ®Google Scholar
• Singh N, Lortholary O, Dromer F, et al. Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantation 2008;86(5):647-51
   PubMedGoogle Scholar
• Davis JA, Costello DJ, Venna N. Laboratory investigation of fungal infections of the central nervous system. Neurol India 2007;55(3):233-40
   PubMedGoogle Scholar
• Antinori S, Radice A, Galimberi L, et al. The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis. J Clin Microbiol 2005;43(11):5828-9
   PubMedGoogle Scholar
• Lindsley MD, Mekha N, Baggett HC, et al. Evaluation of newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis 2011;53(4):321-5
   PubMed Web of Science ®Google Scholar
• Heslop OD, NyiNyi MP, Abbott SP, et al. Disseminated Trichosporonosis in a burn patient: meningitis and cerebral abscess due to Trichosporon asahii. J Clin Microbiol 2011;49(12):4405-8
   PubMed Web of Science ®Google Scholar
• Bariola JR, Perry P, Pappas PG, et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis 2010;50(6):797-804
   PubMed Web of Science ®Google Scholar
• Dobre MC, Smoker WRK, Kirby P. A case of solitary Blastomyces dermatitidis meningitis. Clin Neurol Neurosurg 2011;113(8):665-7
   PubMedGoogle Scholar
• Tai YF, Kullmann DM, Howard RS, et al. Central nervous system histoplasmosis in an immunocompetent patient. J Neurol 2010;257(11):1931-3
   PubMedGoogle Scholar
• Wheat LJ, Musial CE, Jenny-Avital E. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis 2005;40(6):844-52
   PubMed Web of Science ®Google Scholar
• Berger JR, Greenberg RN. Isolated central nervous system histoplasmosis in an immunocompetent patient: 53-month hiatus to diagnosis and treatment. J Neurovirol 2010;16(6):472-4
   PubMed Web of Science ®Google Scholar
• Carvalho C, Ferreira I, Gaiao S, et al. Cerebral coccidioidomycosis after renal transplantation in a non-endemic area. Transpl Infect Dis 2010;12(2):151-4
   PubMed Web of Science ®Google Scholar
• Patel S, Lee RH. The case of sinister spores: the patient was hospitalized for a menacing infection in the second trimester of pregnancy. Am J Obstet Gynecol 2013;208(5):417
   PubMedGoogle Scholar
• Drake KW, Adam RD. Coccidioidal meningitis and brain abscesses. Analysis of 71 cases at a referral center. Neurology 2009;73(21):1780-6
   PubMedGoogle Scholar
• De Almeida SM. Central nervous system paracoccidioidomycosis: an overview. Braz J Infect Dis 2005;9(2):126-33
   PubMedGoogle Scholar
• Le T, Chi NH, Cuc K, et al. AIDS-associated Penicillium marneffei infection of the Central nervous system. Clin Infect Dis 2010;51(12):1458-62
   PubMed Web of Science ®Google Scholar
• Zeng H, Li X, Chen X, et al. Identification of Penicillium marneffei in paraffin-embedded tissue using nested PCR. Mycopathologia 2009;168(1):31-5
   PubMedGoogle Scholar
• Andes D, Casadevall A. Insights into fungal pathogenesis from the iatrogenic epidemic of Exserohilum rostratum fungal meningitis. Fungal Genet Biol 2013;61:143-5
   PubMedGoogle Scholar
• Bell WR, Dalton JB, McCall CM, et al. Iatrogenic Exserohilum infection of the central nervous system: mycological identification and histopathological findings. Mod Pathol 2013;26(2):166-70
   PubMed Web of Science ®Google Scholar
• Arnold C. Fungal meningitis outbreak affects over 700. Lancet Neurol 2013;12(5):429-30
   PubMedGoogle Scholar
• Kauffman CA, Pappas PG, Patterson TF. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med 2013;368(26):2495-500
   PubMedGoogle Scholar
• Feldmesser M. Fungal disease following contaminated steroid injections. Exserohilum is ready for its close up. Am J Pathol 2013;183(3):661-4
   PubMedGoogle Scholar
• Zhao Y, Petraitiene R, Walsh TJ, Perlin DS. A real-time PCR assay for rapid detection and quantification of Exserohilum rostratum, a causative pathogen of fungal meningitis associated with injection of contaminated methylprednisolone. J Clin Microbiol 2013;51(3):1034-6
   PubMed Web of Science ®Google Scholar
• Kainer MA, Reagan DR, Nguyen DB, et al. Fungal infections associated with contaminated methylprednisolone in Tennessee. N Engl J Med 2012;367(23):2194-203
   PubMed Web of Science ®Google Scholar
• Kleinfeld K, Jones P, Riebau D, et al. Vascular complications of fungal meningitis injections of contaminated methylprednisolone. JAMA Neurol 2013;70(9):1173-6
   PubMedGoogle Scholar
• CDC. Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy-United States 2012. MMWR Morb Mortal Wkly Rep 2012;61(41):839-42
   PubMedGoogle Scholar
• Ritter JM, Muehlenbachs A, Blau DM, et al. Exserohilum infections associated with contaminated steroid injections. A clinicopathologic review of 40 cases. Am J Pathol 2013;183(3):881-92
   PubMed Web of Science ®Google Scholar
• Gade L, Scheel CM, Pham CD, et al. Detection of fungal DNA in human body fluids and tissues during a multistate outbreak of fungal meningitis and other infections. Eukaryot Cell 2013;12(5):677-83
   PubMedGoogle Scholar